FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154674502> ?p ?o ?g. }

• W3154674502 abstract "We defined the lethal interaction between the novel therapeutic GZ17-6.02 and the standard of care combination of the MEK1/2 inhibitor trametinib and the B-RAF inhibitor dabrafenib in PDX isolates of cutaneous melanoma expressing a mutant B-RAF V600E protein. GZ17-6.02 interacted with trametinib/dabrafenib in an additive fashion to kill melanoma cells. Regardless of prior vemurafenib resistance, the drugs when combined interacted to prolong ATM S1981/AMPK T172 and eIF2α S51 phosphorylation and prolong the reduced phosphorylation of JAK2 Y1007, STAT3 Y705 and STAT5 Y694. In vemurafenib-resistant cells GZ17-6.02 caused a prolonged reduction in mTORC1 S2448, mTORC2 S2481 and ULK1 S757 phosphorylation; regardless of vemurafenib resistance, GZ17-6.02 caused a prolonged elevation in CD95 and FAS-L expression. Knock down of eIF2α, Beclin1, ATG5, ATM, AMPKα, CD95 or FADD significantly reduced the ability of GZ17-6.02 to kill as a single agent or when combined with the kinase inhibitors. Expression of activated mTOR, activated STAT3, activated MEK1 or activated AKT significantly reduced the ability of GZ17-6.02 to kill as a single agent or when combined with kinase inhibitors; protective effects that were significantly less pronounced in cells treated with trametinib/dabrafenib. Regardless of vemurafenib resistance, the drugs alone or in combination all reduced the expression of PD-L1 and increased the levels of MHCA, which was linked to degradation of multiple HDAC proteins. Our findings support the use of GZ17-6.02 in combination with trametinib/dabrafenib in the treatment of melanomas expressing mutant B-RAF V600E proteins." @default.
• W3154674502 created "2021-04-26" @default.
• W3154674502 creator A5007239425 @default.
• W3154674502 creator A5009999325 @default.
• W3154674502 creator A5069980003 @default.
• W3154674502 creator A5080900202 @default.
• W3154674502 creator A5081743226 @default.
• W3154674502 date "2021-04-08" @default.
• W3154674502 modified "2023-10-16" @default.
• W3154674502 title "GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells" @default.
• W3154674502 cites W1506096984 @default.
• W3154674502 cites W1985928174 @default.
• W3154674502 cites W1986701803 @default.
• W3154674502 cites W2000105750 @default.
• W3154674502 cites W2009338295 @default.
• W3154674502 cites W2009832078 @default.
• W3154674502 cites W2031111848 @default.
• W3154674502 cites W2127258026 @default.
• W3154674502 cites W2136183259 @default.
• W3154674502 cites W2156613731 @default.
• W3154674502 cites W2170255149 @default.
• W3154674502 cites W2344075334 @default.
• W3154674502 cites W2554101470 @default.
• W3154674502 cites W2582602626 @default.
• W3154674502 cites W2597476897 @default.
• W3154674502 cites W2614598056 @default.
• W3154674502 cites W2762797953 @default.
• W3154674502 cites W2776672556 @default.
• W3154674502 cites W2801681624 @default.
• W3154674502 cites W2883794735 @default.
• W3154674502 cites W2892157567 @default.
• W3154674502 cites W2903410741 @default.
• W3154674502 cites W2907431347 @default.
• W3154674502 cites W2948155539 @default.
• W3154674502 cites W2951976042 @default.
• W3154674502 cites W2953798516 @default.
• W3154674502 cites W2969491369 @default.
• W3154674502 cites W2972966486 @default.
• W3154674502 cites W2987654547 @default.
• W3154674502 cites W2999104939 @default.
• W3154674502 cites W3000191756 @default.
• W3154674502 cites W3006719485 @default.
• W3154674502 cites W3009837423 @default.
• W3154674502 cites W3020905210 @default.
• W3154674502 cites W3081610501 @default.
• W3154674502 cites W3090016951 @default.
• W3154674502 doi "https://doi.org/10.3389/fonc.2021.656453" @default.
• W3154674502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8061416" @default.
• W3154674502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33898322" @default.
• W3154674502 hasPublicationYear "2021" @default.
• W3154674502 type Work @default.
• W3154674502 sameAs 3154674502 @default.
• W3154674502 citedByCount "7" @default.
• W3154674502 countsByYear W31546745022022 @default.
• W3154674502 countsByYear W31546745022023 @default.
• W3154674502 crossrefType "journal-article" @default.
• W3154674502 hasAuthorship W3154674502A5007239425 @default.
• W3154674502 hasAuthorship W3154674502A5009999325 @default.
• W3154674502 hasAuthorship W3154674502A5069980003 @default.
• W3154674502 hasAuthorship W3154674502A5080900202 @default.
• W3154674502 hasAuthorship W3154674502A5081743226 @default.
• W3154674502 hasBestOaLocation W31546745021 @default.
• W3154674502 hasConcept C11960822 @default.
• W3154674502 hasConcept C184235292 @default.
• W3154674502 hasConcept C185592680 @default.
• W3154674502 hasConcept C2776131300 @default.
• W3154674502 hasConcept C2777658100 @default.
• W3154674502 hasConcept C2778472372 @default.
• W3154674502 hasConcept C2778830669 @default.
• W3154674502 hasConcept C2780964509 @default.
• W3154674502 hasConcept C2781249067 @default.
• W3154674502 hasConcept C2994587330 @default.
• W3154674502 hasConcept C502942594 @default.
• W3154674502 hasConcept C55493867 @default.
• W3154674502 hasConcept C57074206 @default.
• W3154674502 hasConcept C62478195 @default.
• W3154674502 hasConcept C71924100 @default.
• W3154674502 hasConcept C75217442 @default.
• W3154674502 hasConcept C86554907 @default.
• W3154674502 hasConcept C98274493 @default.
• W3154674502 hasConcept C98490376 @default.
• W3154674502 hasConceptScore W3154674502C11960822 @default.
• W3154674502 hasConceptScore W3154674502C184235292 @default.
• W3154674502 hasConceptScore W3154674502C185592680 @default.
• W3154674502 hasConceptScore W3154674502C2776131300 @default.
• W3154674502 hasConceptScore W3154674502C2777658100 @default.
• W3154674502 hasConceptScore W3154674502C2778472372 @default.
• W3154674502 hasConceptScore W3154674502C2778830669 @default.
• W3154674502 hasConceptScore W3154674502C2780964509 @default.
• W3154674502 hasConceptScore W3154674502C2781249067 @default.
• W3154674502 hasConceptScore W3154674502C2994587330 @default.
• W3154674502 hasConceptScore W3154674502C502942594 @default.
• W3154674502 hasConceptScore W3154674502C55493867 @default.
• W3154674502 hasConceptScore W3154674502C57074206 @default.
• W3154674502 hasConceptScore W3154674502C62478195 @default.
• W3154674502 hasConceptScore W3154674502C71924100 @default.
• W3154674502 hasConceptScore W3154674502C75217442 @default.
• W3154674502 hasConceptScore W3154674502C86554907 @default.
• W3154674502 hasConceptScore W3154674502C98274493 @default.
• W3154674502 hasConceptScore W3154674502C98490376 @default.

• next